Budesonide + Formoterol 200/6mcgInhaler
Respiratory

Budesonide + Formoterol 200/6mcg

Budesonide + Formoterol Fumarate

ICS-LABA combination inhaler for maintenance and reliever therapy (MART) in asthma and COPD. Manufactured by Cipla and Sun Pharma for respiratory export.

Strengths

100/6mcg / 200/6mcg / 400/6mcg

Packing

120 doses inhaler

Origin

India (WHO-GMP)

MOQ

100 units

Export Price

On Request

Availability

In Stock

Quotation with pricing, availability, and shipping timeline sent within 24 hours.

Product Specifications

Composition
Budesonide 200mcg + Formoterol Fumarate Dihydrate 6mcg per actuation
Dosage Form
Inhaler
Available Strengths
100/6mcg / 200/6mcg / 400/6mcg
Packing
120 doses inhaler
Route of Administration
Inhalation
Dosage
Maintenance: 1-2 puffs twice daily; MART: 1 puff twice daily maintenance + 1 puff as needed for relief; max 8 puffs/day
Indications
Asthma (maintenance and reliever therapy), COPD with frequent exacerbations
Country of Origin
India (WHO-GMP Certified)
Storage
Store below 30°C
Shelf Life
24 months
Side Effects
Oral candidiasis, hoarseness, headache, tremor, palpitations, throat irritation
Precautions
Rinse mouth after each use to prevent oral candidiasis; not for acute rescue alone; MART approach reduces exacerbation risk; monitor growth in children

Disclaimer: This information is intended for healthcare professionals and international pharmaceutical buyers only. Product availability, registration status, and approved indications may vary by country. All products are supplied with Certificate of Analysis (CoA), commercial invoice, and packing list. Rx products require valid prescription in the destination country.

Need bulk pricing for Budesonide + Formoterol 200/6mcg?

Send us your quantity requirements and destination country for a custom quotation.

Get Bulk Quote